Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

stem cells Press Releases

  + XML/RSS  



By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.

By MD Stem Cells
MD Stem Cells announces expansion of stem cell treatment for eye disease to Dubai, UAE.

By Mary Ann Liebert, Inc., publishers
Marina Cavazzana, MD, PhD, Paris Descartes University, and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders.

By Pharmco Skincare Labs
Swiss Apple Stem Cells integrated with a unique blend of ingredients to create luxurious eye cream.

By Blue Horizon International
Blue Horizon International Founder and Others Attend 2014 Winter Olympics, Discuss Stem Cell Treatments for Sports-Related Injuries, Recovery

By Bioethics Defense Fund
Paper published in globally recognized journal clears the confusion in the field of stem cell research, both within the scientific community and in the general public, about what is, and what is not a human embryo.

By Mary Ann Liebert, Inc., publishers
The ability to reprogram adult cells so they return to an undifferentiated, pluripotent state—much like an embryonic stem cell—is enabling the development of promising new cell therapies.

By Blue Horizon International
World-renowned stem cell researcher introduces studies on first high potency stem cell treatments at the World Economic Forum in Davos

By Blue Horizon International
Blue Horizon International Founder to attend Grammy Awards to discuss stem cell research

By Blue Horizon International
World-renowned stem cell researcher and orthopedic surgeon set to introduce studies on high potency stem cell treatments at the World Economic Forum

By Mary Ann Liebert, Inc., publishers
Mary Ann Liebert, Inc., publishers announced the publication of the World Stem Cell Report 2013, a special supplement to the peer-reviewed journal Stem Cells and Development.

By Blue Horizon International
Janice Dickinson Expected to Join Dr. Brian Mehling, Founder of Blue Horizon International, at Event to Discuss Stem Cell Treatments, Special Skin Serum.

By Mary Ann Liebert, Inc., publishers
Contact: Jennifer Quigley, Mary Ann Liebert, Inc., (914) 740-2100, jquigley@liebertpub.com Mary Ann Liebert to Receive Award for Stem Cell Education at World Stem Cell Summit in San Diego New Rochelle, NY-The Genetics Policy Institute (GPI) will bestow...

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext.

By Wragg & Casas Public Relations
Bioheart, a leader in developing stem cell therapies to treat cardiovascular diseases, has expanded its team by adding three key strategic positions with regulatory, finance and administrative expertise.

By ADULT STEM CELL FOUNDATION
The ASCF is pleased to announce this significant honorary appointment to our Advisory Board. Dr Soraya Felix as you can read is probably one of the most qualified doctors in Australia and beyond.

By tebu-bio
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.

By Skin Perfection LLC
Look great this summer with Anti Aging, Natural & Organic Skin Care from Skin Perfection, our superior formulas use scientifically proven, highly effective peptides along with natural and organic botanicals that diminish the look of wrinkles, increasing..

By Axiogenesis
Includes sub-licensing patent portfolio of disease models and drug development assays utilizing iPSC-derived cell types

By Mary Ann Liebert, Inc., publishers
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.

All Press Releases

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn , Mary Ann Liebert, Inc., (914) 740-2100, ext.

By PRONicaragua
Nicaragua is the first country in the world to successfully regenerate an artery with stem cells extracted from human fat and not from bone marrow, as is currently done in Germany and some Asian countries.

By MD Stem Cells
MD Stem Cells announces expansion of stem cell treatment for eye disease to Dubai, UAE.

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext.

By Mary Ann Liebert, Inc., publishers
Marina Cavazzana, MD, PhD, Paris Descartes University, and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders.

By Pharmco Skincare Labs
Swiss Apple Stem Cells integrated with a unique blend of ingredients to create luxurious eye cream.

By Blue Horizon International
Blue Horizon International Founder and Others Attend 2014 Winter Olympics, Discuss Stem Cell Treatments for Sports-Related Injuries, Recovery

By Bioethics Defense Fund
Paper published in globally recognized journal clears the confusion in the field of stem cell research, both within the scientific community and in the general public, about what is, and what is not a human embryo.

By Mary Ann Liebert, Inc., publishers
The ability to reprogram adult cells so they return to an undifferentiated, pluripotent state—much like an embryonic stem cell—is enabling the development of promising new cell therapies.

By Blue Horizon International
World-renowned stem cell researcher introduces studies on first high potency stem cell treatments at the World Economic Forum in Davos

By Blue Horizon International
Blue Horizon International Founder to attend Grammy Awards to discuss stem cell research

By Blue Horizon International
World-renowned stem cell researcher and orthopedic surgeon set to introduce studies on high potency stem cell treatments at the World Economic Forum

By Alstembio
Last fall when two scientists were awarded the Nobel Prize for their work reprogramming mature human cells to become pluripotent, two Santa Clara bioengineering students were especially excited: they were already helping to commercialize the technology...

By MD Stem Cells
10 key advances in Stem Cell treatments and research from 2013 identified by MD Stem Cells.

By MD Stem Cells
MD Stem Cells reveals the 5 critical points in the decision making process.

By MD Stem Cells
MD Stem Cells hopeful that SCOTS stem cell eye study will benefit blinding eye disease caused by.

By Mary Ann Liebert, Inc., publishers
Mary Ann Liebert, Inc., publishers announced the publication of the World Stem Cell Report 2013, a special supplement to the peer-reviewed journal Stem Cells and Development.

By Blue Horizon International
Janice Dickinson Expected to Join Dr. Brian Mehling, Founder of Blue Horizon International, at Event to Discuss Stem Cell Treatments, Special Skin Serum.

By Mary Ann Liebert, Inc., publishers
Contact: Jennifer Quigley, Mary Ann Liebert, Inc., (914) 740-2100, jquigley@liebertpub.com Mary Ann Liebert to Receive Award for Stem Cell Education at World Stem Cell Summit in San Diego New Rochelle, NY-The Genetics Policy Institute (GPI) will bestow...

By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext.

By MD Stem Cells
MD Stem Cells sees no immediate effect on the SCOTS eye stem cell trial but is monitoring NIH throughout the government shutdown.

By Innovative Cosmetic Surgery
Regenerative Medicine progresses with groundbreaking stem cell therapy, expanding and improving the use of adipose (fat) stem cells in treating degenerative and inflammatory diseases such as multiple sclerosis (MS), Parkinson’s and Lupus.

By Wragg & Casas Public Relations
Bioheart, a leader in developing stem cell therapies to treat cardiovascular diseases, has expanded its team by adding three key strategic positions with regulatory, finance and administrative expertise.

By ADULT STEM CELL FOUNDATION
The ASCF is pleased to announce this significant honorary appointment to our Advisory Board. Dr Soraya Felix as you can read is probably one of the most qualified doctors in Australia and beyond.

By tebu-bio
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.

By Skin Perfection LLC
Look great this summer with Anti Aging, Natural & Organic Skin Care from Skin Perfection, our superior formulas use scientifically proven, highly effective peptides along with natural and organic botanicals that diminish the look of wrinkles, increasing..

By CRC Press
Regenerative Engineering introduces the field through the presentation of fundamental concepts of cell biology, stem cell science, materials science, and cell-material interactions.

By Axiogenesis
Includes sub-licensing patent portfolio of disease models and drug development assays utilizing iPSC-derived cell types

By Florida Spine Center
Sports Medicine of the future. New and effective treatments for athletes

By GoodPartners, Inc
Contact: Natalie Winehouse 503.446.5039 pr@goodpartnersinc.com oodpartnersinc.com GoodPartners Launches First Global Survey into Stem Cell Usage Portland, Oregon. Wednesday, May 15, 2013.

By MD Stem Cells
MD Stem Cells Reports Billion Cell Harvests For Eye Stem Cell Treatments in Florida.

By MD Stem Cells
Post-operative visual acuity significantly improved following stem cell treatment for Macular Degeneration according to an independent Optometrist in California

By Mary Ann Liebert, Inc., publishers
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.

By Medical Alliance Services
Mark E. Johnson, M.D, Ph.D, now offers the innovative procedure TICKLE LIPO™ at Advanced Body Sculpting in Kennewick, WA, to help his patients to get rid of stubborn fat deposits in specific areas of the body.

By MD Stem Cells
Macular Degeneration is a common progressive retinal condition that destroys the central vision for patients – many times as they are just entering retirement and find their visual needs for reading and driving increasing.

By Medical Alliance Services
What is Cell Rich Fat Transfer? Cell Rich Fat Transfer by Tickle Lipo™ is a simple, fast, gentle, and low cost fat harvesting/transfer method, which yields quality reinjectable adipose tissue with high potency of adipose derived regenerative cells...

By Medical Alliance Services
Medical Alliance Services, the exclusive US distributor of Nutational Infrasonic Liposculpture (N.I.L.), has recently announced their new significantly reduced prices for 2013.

By MD Stem Cells
92 year old shows rapid vision results with stem cells. Age is not a barrier to visual improvement following stem cell treatment reports MD Stem Cells.

By MD Stem Cells
New Intravitreal Stem Cell Injection Approach to Improve Vision is Now Available through MD Stem Cells.

By MD Stem Cells
MD Stem Cells Reports Almost Two Billion Cells Used in Eye Stem Cell Treatment.

By Cambridge Healthtech Institute
To be held on February 11-12, 2013 at the Moscone North Convention Center, San Francisco, CA - Part of the Molecular Med TRI-CON 2013.

By Margaret Lamb
Dr. Steven A. Meixel will give a lecture on stem cells Jan. 30 in Murrells Inlet.

By American Academy of Neurology
SAN DIEGO – Apparent stem cell transplant success in mice may hold promise for people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.

By MD Stem Cells
MD Stem Cells helps Australian patient travel half way around the world for stem cell treatment in Florida - rewarded with major improvement in vision

By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Data Visualization in Biology: From the Basics to Big Data Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco.

By Intercellular Sciences, LLC
"I have my wife of 60 years back," Says Mary's husband following a two week follow up visit with her doctor. She was treated with her own stem cells for dementia. Now, one month later, she continues to show improvement.

By Intercellular Sciences, LLC
An 82 year old woman was treated with her own stem cells for dementia. Her symptoms have been successfully reversed.

By Cambridge Healthtech Institute
Cambridge Healthtech Institute's Identification & Characterization of Cancer Stem Cells Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at The Moscone North Convention Center in San Francisco.

By Mary Ann Liebert, Inc., publishers
A method for genetically engineering hMSCs so they become immortal and still retain their ability to become bone cells is described in an article published in BioResearch Open Access.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share